ACM
GSK icon

AlphaStar Capital Management’s GSK GSK Stock Holding History

AlphaStar Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,626
Closed -$330K – 201
2019
Q4 		$330K Buy
5,626
+964
+21% +$53.6K 0.07% 165
2019
Q3 		$249K Buy
4,662
+154
+3% +$7.92K 0.06% 190
2019
Q2 		$226K Buy
+4,508
New +$226K 0.06% 202

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

AlphaStar Capital Management's GSK Position: Q1 2020 in Review

AlphaStar Capital Management sold out of GSK (GSK) in Q1 2020, closing a stake of 5,626 shares — an estimated $330K sold.

AlphaStar Capital Management first reported a position in GSK in Q2 2019 and held it in 3 quarters. The position peaked at $330K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • AlphaStar Capital Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • AlphaStar Capital Management sold 5,626 GSK shares in Q1 2020, an estimated $330K.
  • AlphaStar Capital Management first reported a position in GSK in Q2 2019 and held it in 3 quarters.
  • AlphaStar Capital Management's GSK position peaked at $330K in Q4 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on AlphaStar Capital Management's 13F filing for Q1 2020, filed 5 May 2020.